Global University Venturing

Volpara Health has acquired CRA Health, a spinout of Havard Medical School’s teaching hospital Massachusetts General Hospital.

The firm announced its second fund the same day as one of its portfolio companies, University of Wyoming-backed Momentus, successfully listed on Nasdaq.

Harvard-linked Sana Biotechnology will raise as much as $397m if it floats at the upper end and underwriters take up the greenshoe option.

An undisclosed US university endowment has helped the consumer-focused venture firm hit a $118m final close for its second fund, surpassing its $100m target in the process.

SR One reinvested in a series B round for the degenerative disorder drug developer that was led by venture fund Logos Capital.

Georgia Tech-linked battery technology producer Sila Nanotechnologies has more than tripled its valuation to $3.3bn in the series F round.

GV and Novartis Venture Fund joined 6 Dimensions Capital in a round that brought Harvard’s oncology drug developer's overall funding to $160m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The firm, which specialises in commercialising public and corporate research, has closed its largest fund to date.

The symbiosis between education and the life sciences sector has been ever present, where universities typically make up a large part of the real estate servicing life sciences companies.

What are the most important aspects of a technology for a venture capital investor?